Welcome Visitor, Sign Up for Free!

Morphine Sulfate Injection Recall

On March 18, 2012 the FDA issued a recall for Morphine Sulfate Injection USP, 4 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject, NDC 0409-1258-30, due to a customer report of two Carpujects syringes containing more than the 1 mL labeled fill volume. Vials of this medication were distributed to an unknown number of hospitals in Arizona, Colorado, Hawaii, Illinois, Indiana, Michigan, Minnesota, Ohio, Texas and Virginia. The injectable morphine, an opioid pain medication, in the same class of drugs as Darvocet, and OxyContin, was also distributed to some wholesalers.

Morphine is used in as a pre-anaesthesia medication to reduce the anxiety of patients as well as lessen the amount of anesthetic required to complete a procedure. It is to be administered by subcutaneous or intramuscular injection at the intervals prescribed by a physician.

The consequences of receiving an accidental overdose of morphine sulfate injection include respiratory depression, coma, and death. If you have any of the product from the aforementioned lot, please send your  DEA 222 form to Hospira, 1635 Stone Ridge Drive, Stone Mountain, GA 30083 to order a replacement.